Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides.

Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides. Abstract Text:

Natasha T Snider,Andrei M Kornilov,Ute M Kent,Paul F Hollenberg,

The endocannabinoid anandamide is an arachidonic acid derivative that is found in most tissues where it acts as an important signaling mediator in neurological, immune, cardiovascular, and other functions. Cytochromes P450 (P450s) are known to oxidize arachidonic acid to the physiologically active molecules hydroxyeicosatetraenoic acids (HETEs) and epoxyeicosatrienoic acids (EETs), which play important roles in blood pressure regulation and inflammation. To determine whether anandamide can also be oxidized by P450s, its metabolism by human liver and kidney microsomes was investigated. The kidney microsomes metabolized anandamide to a single mono-oxygenated product, which was identified as 20-HETE-ethanolamide (EA). Human liver microsomal incubations with anandamide also produced 20-HETE-EA in addition to 5,6-, 8,9-, 11-12, and 14,15-EET-EA. The EET-EAs produced by the liver microsomal P450s were converted to their corresponding dihydroxy derivatives by microsomal epoxide hydrolase. P450 4F2 was identified as the isoform that is most probably responsible for the formation of 20-HETE-EA in both human kidney and human liver, with an apparent Km of 0.7 microM. The apparent Km values of the human liver microsomes for the formation of the EET-EAs were between 4 and 5 microM, and P450 3A4 was identified as the primary P450 in the liver responsible for epoxidation of anandamide. The in vivo formation and biological relevance of the P450-derived HETE and EET ethanolamides remains to be determined.

Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides. Publishing Authors By Initials

NT Snider,AM Kornilov,UM Kent,PF Hollenberg,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: The Journal of pharmacology and experimental thera

VOLUME: 321

Page Numbers: 590-7

Journal Abbreviation:

ISSN: 0022-3565

DAY: 1

MONTH: 02

YEAR: 2007

Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 376362

Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides. Keywords Mesh Terms:

KEYWORDS: Spectrometry, Mass, Electrospray Ionizat

MESH TERMS: metabolism

Chemical & Substance for Abstract: Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides. Information

Substance Name: CYP3A4 protein, human

Registry Number: EC 1.14.13.67

Grant and Affiliation Information for Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides.

AFFILIATION: Department of Pharmacology, University of Michigan, 2301 MSRB III, 1150 West Medical Center Drive, Ann Arbor, Michigan 48109-0632, USA.

Country: United States

AGENCY: United States NIGMS

GRANT: T32 GM007767

ACRONYM: GM

MEDLINETA: J Pharmacol Exp Ther

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides Related Publications

• 5th International Symposium on receptor mechanisms, signal transduction and drug effects.
• Aging and vascular responses to flavanol-rich cocoa.
• Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides.
• Bleeding from the nipple.
• Blood pressure responses to lifestyle physical activity among young, hypertension-prone African-American women.
• Cocaine- and methamphetamine-induced acute cerebral vasospasm: an angiographic study in rabbits.
• Color Doppler sonography of patellar tendinosis.
• Compressive meningeal hypertrophy in mucopolysaccharidosis.
• Effects of eleven isothiocyanates on P450 2A6- and 2A13-catalyzed coumarin 7-hydroxylation.
• Effects of the PPAR-gamma agonist rosiglitazone on renal haemodynamics and the renin-angiotensin system in diabetes.
• Gender and the renal nitric oxide synthase system in healthy humans.
• Mortality in type 2 diabetes mellitus.
• Mutation of a single residue (K262R) in P450 2B6 leads to loss of mechanism-based inactivation by phencyclidine.
• Peroxynitrite Inactivation of Human Cytochrome P450s 2B6 and 2E1: Heme Modification and Site-Specific Nitrotyrosine Formation.
• Prorenin and angiotensin-dependent renal vasoconstriction in type 1 and type 2 diabetes.
• Proteinase-activated receptors, targets for kallikrein signaling.
• Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.
• Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems.
• Renin inhibition: what are the clinical perspectives?
• Short- and long-term glycaemic control and the state of the renin system in type 1 diabetes mellitus.
• Sodium-sensitive essential hypertension: emerging insights into an old entity.
• Structure-activity relationship and elucidation of the determinant factor(s) responsible for the mechanism-based inactivation of cytochrome P450 2B6 by substituted phenyl diaziridines.
• Synthesis of substituted phenyl diaziridines and characterization as mechanism-based inactivators of human cytochrome P450 2B6.
• THE USE OF TENDON SURGERY TO IMPROVE FUNCTION OF THE HAND IN QUADRIPLEGIA.
• The Role of the Thyrotropin-Releasing Hormone (TRH) Neuron as a Metabolic Sensor.
• The inactivation of cytochrome P450 3A5 by 17alpha-ethynylestradiol is cytochrome b5-dependent: metabolic activation of the ethynyl moiety leads to the formation of glutathione conjugates, a heme adduct, and covalent binding to the apoprotein.
• The renin rise with aliskiren: it's simply stoichiometry.
• The renin-angiotensin system and cardiovascular disease.
• Towards a picosecond transform-limited nitrogen-vacancy based single photon source.
• Vasopressor support in septic shock.